Lineage Therap(IL:LCTX)
ILA 346.60+20.90 (+6.42%)
IL:LCTX
Lineage Therap earnings date
ILA 346.60
At close:+20.90 (+6.42%)
Lineage Therap (LCTX) Q2 2018 Earnings Report
3 Followers
IL:LCTX Q2 2018 EPS Results
- Actual EPS
- -ILA 8.94
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -ILA 32.56
IL:LCTX Q2 2018 Revenue Results
- Actual Revenue
- ILA 813.13M
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/02/2018
- Time
- After Close
- Conference Call
- Thursday, August 2, 2018
IL:LCTX Upcoming Earnings
Lineage Therap's next earnings date is estimated for March 11, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
IL:LCTX Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 11, 2027 | 2026 (Q4) | -5.43- | 1.28 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -9.26-9.58 | -41.5 | 76.92% (+31.93) | |
| Aug 06, 2026 | 2026 (Q2) | -8.94-9.58 | -41.5 | 76.92% (+31.93) | |
| May 12, 2026 | 2026 (Q1) | -6.39-9.58 | -6.39 | -50.00% (-3.19) | |
| Mar 05, 2026 | 2025 (Q4) | -13.731.28 | -6.39 | 120.00% (+7.66) | |
| Nov 06, 2025 | 2025 (Q3) | -8.30-41.50 | -6.39 | -550.00% (-35.12) | |
| Aug 12, 2025 | 2025 (Q2) | -8.62-41.50 | -9.58 | -333.33% (-31.93) | |
| May 13, 2025 | 2025 (Q1) | -8.30-6.39 | -12.77 | 50.00% (+6.39) | |
| Mar 10, 2025 | 2024 (Q4) | -9.58-6.39 | -9.58 | 33.33% (+3.19) | |
| Nov 14, 2024 | 2024 (Q3) | -12.77-6.39 | -12.77 | 50.00% (+6.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
